Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Nov 10, 2025 · 10-Q · 41 days after period end · 0001520138-25-000343
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$5.09M | -$4.15M | -$10.71M | -$10.42M |
| EPS Diluted | -$0.98 | -$0.70 | -$2.92 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 10, 2025 · 41 d after period end
